Abstract
Ankyrins

Ankyrins are a family of adaptor proteins that link integral membrane proteins with the submembranous actin/␤-spectrin cytoskeleton. The first ankyrin was characterized over 30 years ago as an adaptor protein that tethered the anion exchanger to ␤-spectrin in red blood cells [1]. Ankyrins are now regarded as pivotal choreographers in the formation of protein complexes consisting of ion channels and transporters, cell adhesion molecules, signalling proteins and cytoskeletal elements. These ankyrin-associated protein complexes comprise specialized membrane domains with distinct electrogenic and/or structure properties in eukaryotic cells. In addition, new functions now ascribed to ankyrin include membrane biogenesis and the formation of diffusion barriers that maintain the subcellular polarity of migrating proteins.
Ankyrin functional domains
The prototypical ankyrin consists of three functional domains (Fig. 1) . The membrane-binding domain, which mediates ankyrin binding to integral membrane proteins, contains 24 ANK repeats assembled as a superhelical spiral. An ANK repeat consists of 33 amino acids arranged as two anti-parallel ␣-helices followed by a long loop [2] . Adjacent ANK repeats are connected by a ␤-hairpin loop and these solvent-exposed domains mediate protein interactions. The binding sites are often spread across adjacent ␤-hairpin loop tips. For example, ankyrin interacts with the sodium/calcium exchanger (NCX) via ANK repeats [16] [17] [18] [3] , the inositol (1, 4, 5) triphosphate receptor (IP3 receptor) via ANK repeats 22-24 [4] and the voltage-gated sodium channel via ANK repeats 14 and 15 [5] . Additional integral membrane proteins that interact with the ankyrin membrane-binding domain include the anion exchanger [6] [7] [8] , sodium/potassium ATPase (NKA) [9, 10] , voltage-gated potassium channel subunits (KCNQ2 and KCNQ3) [11] [12] [13] [14] and the L1 family of cell adhesion molecules ( Fig. 1) [15, 16] .
The ankyrin associated protein complex are tethered to the actin/spectrin cytoskeleton via its spectrin-binding domain. This domain is relatively large with a molecular weight of 62 kD, but the minimal spectrin-binding domain is contained within a 160 amino acid ZU-5 motif [17] . This motif has two conserved sites that are critical for spectrin-binding activity (ankyrin-B: DAR976, A1000 and ankyrin-G: DAR999, A1024) [17, 18] . For ␤-spectrin, the minimal ankyrin-binding domain is contained in spectrin repeats 14 and 15 [19-21] (Fig. 1 ).
Ankyrin genes, alternative splicing and the diversity of ankyrin polypeptides
The diversity of ankyrin polypeptides is the product of unexpectedly complex alternative splicing of three genes (see Table 1 [65] . Interestingly, neither the PH nor the ankyrin-binding domains are required for ␤-spectrin localization in salivary epithelial cells [65] . In fact, the novel targeting motif has yet to be identified. Ankyrin-independent ␤-spectrin targeting mechanisms may include phospholipids, integral membrane proteins (␣-catenin) [66] [67] [68] [69] .
and additional adaptor proteins (4.1 protein) [53]. Similar to ␤-spectrin, multiple ankyrin-G domains contribute to its retention at specific membrane domains. For example, axolemmal targeting information is contained in the ankyrin-G spectrinbinding and C-terminal regulatory domains [49]. Furthermore, additional targeting motifs that restrict ankyrin-G expression to AIS are present in the serine/threonine rich and C-terminal regulatory domains [49]. These findings suggest that ankyrin-G targeting to AIS is dependent on multiple protein interactions with different ankyrin-G domains. Apparent discrepancies in the targeting and retention of ankyrin/spectrin complexes to different membrane domains may be explained by the involvement of multiple proteins. For example, as will be described in greater detail below, the cell adhesion molecule neurofascin recruits ankyrin-G to the nodes of Ranvier, but not to AIS of peripheral neurons
L1-cell adhesion molecules
Ankyrins bind to a variety of cell adhesion molecules including CD44 [70] , E-cadherin [71] , ␤-dystroglycan [72] and members of the L1 family [15, 16] [78, 79] . [80] . Similarly, in hippocampal neurons ankyrin-G depletion by RNA interference extinguishes AIS targeting of neurofascin-186, NaV 1.6, and ␤4-spectrin [81] . As in the central nervous system, ankyrin-G recruits neurofascin-186 to AIS of peripheral neurons, but interestingly their roles are reversed at the nodes of Ranvier (Fig. 2) . Specifically, neurofascin-186 recruits ankyrin-G to the nodes of peripheral neurons [67] [68] [69] . Consistent with this finding, neurofascin-186 clusters at the nodes before ankyrin-G or voltage-gated sodium channels [82, 83] . The nodal clustering of neurofascin-186 is mediated by direct interactions between its extracellular domain and gliomedin, an extracellular matrix protein that accumulates in the perinodal region after being cleaved from the membrane surface of Schwann cell microvilli [84] . Decreasing gliomedin expression through RNA interference reduces the nodal expression of both neurofascin and NaV channels [84] [85, 86] . Loss of obscurin activity causes the misalignment of M-lines in adjacent myofibrils and reduced myosin incorporation into maturing thick filaments [85, 87] [88] . In zebrafish, obscurin deficiency due to antisense morpholino treatment results in ventricular hypoplasia and a reduced heart rate [89] . Obscurin mutations have been also associated with human cardiomyopathy [90] .
The relative contribution of ankyrin or L1 proteins to the targeting and retention of the other depends on the membrane domain. For example, ankyrin-G recruits neuronal isoforms of neurofascin (neurofascin-186) to AIS of cerebellar Purkinje neurons
While (Fig. 3) [93] . Interestingly, titin mutations within the region of the obscurinbinding site are associated with tibial muscular dystrophy and limb girdle muscular dystrophy [94] [95] [96] .
In ventricular cardiomyocytes, ankyrin-B is localized at two distinct domains: overlying the structural and myofibrillar proteins of the M-line and at the SR/T-tubule junctions (Fig. 3) . [97] . [50, 51, 98] . [99] . Nevertheless, Table 2 ) [100] [101] [102] . The following sections will present diseases associated with ankyrin dysfunction in the erythrocyte, heart and brain. [109] . Additional support for ankyrin function in synaptogenesis comes from genetic screens that identified the large isoform of Drosophila ankyrin 2 as a critical regulator of synaptic stability and maintenance at the Drosophila neuromuscular junction [110, 111] [110, 111] . [80] . In the absence of ankyrin-G, Purkinje neurons display impaired ability to initiate action potentials and the mice demonstrate neuronal degeneration of the cerebellum and progressive motor ataxia [80] . [45, 112, 113] . By disrupting the association of ankyrin-G and NaV1.5, this mutation impairs ankyrin-G dependent targeting of the channel to the intercalated disc resulting in decreased sodium channel current density (INa) [5, 45] . Similar ankyrinbinding motifs are also present in the voltage-gated potassium channel subunits KCNQ2 and KCNQ3. These motifs are required for ankyrin-dependent targeting of these channel subunits to AIS where they control overall neuronal excitability [11, 13, 14] . [72] . A dystrophin mutation linked to Becker muscular dystrophy was shown to reduce ankyrin binding thereby resulting in decreased sarcolemmal localization of dystrophin [72] . Table 2 ). [120] [121] [122] [123] . The neuropathology manifested in ankyrin-B deficient mice may also arise in part from a loss of ankyrin-B dependent targeting of ␤-dystroglycan to astrocyte endfeet, which ensures the compact formation of the glia limitans that serves as an interface between cerebral spinal fluid and the brain [72] .
Recently, it was demonstrated that a subpopulation of ankyrin-B is targeted to the M-line via its interaction with the C-terminal domain of 800 kD obscurin [97]. This interaction is regulated by alternative splicing of an exon in the C-terminal regulatory domain that dramatically increases obscurin-binding activity of ankyrin. Moreover, it was demonstrated that a regulatory subunit of protein phosphatase 2A, a signalling molecule that controls the phosphorylation status of proteins such as myosin-binding protein C and troponin-I, is brought to the M-line via ankyrin-B/obscurin interactions
In addition to ankyrin-B, small ankyrin-R isoforms 1.5 and 1.9 interact with the carboxyl-terminus of 800 kD obscurin [50, 51, 98]. These small ankyrins are unique because they lack many of the domains found in a prototypical ankyrin. In fact, they only retain a small portion of the C-terminal regulatory domain of ankyrin-R. The amino terminal domain contains a novel stretch of amino acids that forms a transmembrane domain that integrates into the membrane of the SR. Based on their interactions with obscurin, these small isoforms are targeted to the M-line where it is thought that they position the developing SR in reference to myofibrils
Ankyrins and disease
As the field of ankyrin biology continues to advance, the clinical manifestations of ankyrin dysfunction will be recognized as complex and multi-systemic for a number of reasons. First, ankyrins (R, G, B) and their alternative isoforms are expressed in many tissues (see Table 1). Often they display overlapping expression patterns in the same tissues. For example, isoforms of all three ankyrins are expressed in brain, heart and skeletal muscle. Findings from ankyrin knockout mouse models and cell-based structure/function analysis suggest that ankyrins are not functionally redundant. For example, ankyrin-G does not compensate for ankyrin-B loss in ventricular cardiomyocytes
Fig. 3 Ankyrin-B localization in ventricular cardiomyocytes. Ankyrin-B is targeted to the M-line via its interaction with the C-terminal domain of the large sarcomeric protein obscurin. Obscurin is targeted to the M-line via its N-terminal interactions with myomesin and titin. This population of ankyrin-B recruits B56␣, a regulatory subunit of protein phosphatase 2A, to the M-line where the phosphatase may regulate the phosphorylation status of contractile and signalling proteins. Another population of ankyrin-B is located at the Z-lines where they interact with ion channels and transporters that regulate calcium efflux from the SR/T-tubule junction. The protein network associated with this ankyrin-B subpopulation includes NCX, NKA and the inositol(1,4,5) triphosphate receptor (IP3R
Ankyrin-R While ankyrin-R is expressed in red blood cells, muscle tissue and neurons, the most prominent phenotype associated with ankyrin-R mutations is hereditary sphereocytosis. This haemolytic anaemia is characterized by increased haemolysis due to altered red blood cell morphology from the normal biconcave disk to a spherical conformation. Although it is rare, some neurological problems have been associated with hereditary sphereocytosis [103]. As a model of ankyrin-R deficiency, normoblastosis (nb/nb) mice display motor ataxia in addition to severe haemolytic anaemia [32, 104]. These deficiencies are the result of a hypomorphic mutation in ankyrin-R [105] and the movement disorder is consistent with the predominant expression of ankyrin-R in the cell bodies and dendrites of Purkinje and granule cells of the cerebellum [32, 104]. While multiple ankyrin-R isoforms have been characterized in skeletal muscle, no muscular dystrophies in human have been associated with ankyrin-R dysfunction.
Ankyrin-G
Recently, multiple genome wide association studies have linked single nucleotide polymorphisms in the ANK3 locus to bipolar disorder, a mental illness characterized by recurring episodes of mania and depression [106-108]. Considering neurotransmitters commonly associated with mood disorders (i.e. serotonergic, dopaminergic and cholinergic neurotransmitters) are not preferentially affected in bipolar disorder, the molecular basis for bipolar disorder may reflect wholesale changes to synaptic connectivity and neural circuitry. This view is consistent with the loss of synaptic connectivity between basket interneurons and Purkinje neurons in ankyrin-G deficient cerebellums [109]. To regulate neuronal excitability, basket interneurons form GABAergic synapses with AIS of Purkinje neurons, a developmental process guided by an ankyrin-G dependent subcellular gradient of neurofascin in Purkinje neurons
. Specifically, the loss of this ankyrin precipitates the disassembly and retraction of presynaptic boutons, caused by cytoskeletal destabilization following the loss of an interaction between synaptic microtubules and the extended C-terminal domain of this ankyrin
Another mechanism by which ankyrin-G impacts overall neural circuitry is through its targeting of voltage-gated sodium and potassium channels to AIS and nodes of Ranvier in neurons of the central nervous system. For example, ankyrin-G directs the targeting of voltage-gated sodium channels to AIS of granule cells and Purkinje neurons
Many disease-related mutations have been characterized in ankyrin-G associated proteins. For example, a mutation in cardiac voltage-gated sodium channel NaV1.5 was shown to disrupt the channel's association with ankyrin-G and to cause Brugada syndrome, a cardiac disorder characterized by precordial ST segment elevation, right bundle branch block, and fatal arrhythmias [5, 45]. The Brugada syndrome mutation (E1053K) resides within a 9 amino acid ankyrin-binding motif that is highly conserved in the DII-DIII loops of voltage-gated sodium channels
Ankyrin-B While ankyrin-B is expressed in a variety of tissues, human mutations to ankyrin-B have almost exclusively been associated with cardiac disorders (see
In many animal models, both ankyrin and L1 are involved in axonal guidance and fasciculation. For example, mutations to the ankyrin-related gene unc-44 in C. elegans result in abnormal axonal guidance and fasciculation [124, 125] . Likewise, mutations to the Drosophila homologue of L1 neuroglian cause abnormal pathfinding of motorneuron projections and impaired contralateral projections of olfactory receptor neurons [126, 127] . Two different mechanisms have been shown to regulate L1-mediated axonal guidance and neurite outgrowth. First, L1 interacts with neuropilin-1, which is a receptor for the semaphorin family of chemoattractants and repellents [128] [129] [130] [132, 133] . 
Conclusions
